Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism

被引:288
作者
Spires, TL [1 ]
Grote, HE [1 ]
Varshney, NK [1 ]
Cordery, PM [1 ]
van Dellen, A [1 ]
Blakemore, C [1 ]
Hannan, AJ [1 ]
机构
[1] Univ Oxford, Physiol Lab, Oxford OX1 3PT, England
基金
英国惠康基金;
关键词
Huntington's disease; environmental enrichment; BDNF; DARPP-32; transgenic mouse model; R6/1; NGF;
D O I
10.1523/JNEUROSCI.1658-03.2004
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington's disease (HD) is a devastating neurodegenerative disorder caused by a CAG repeat expansion encoding an extended polyglutamine tract in the huntingtin protein. Transgenic mice expressing a human huntingtin transgene containing an expanded CAG repeat (R6/1 model) develop a neurodegenerative disorder closely resembling human HD. Previous work demonstrated that environmental enrichment delays the onset of motor symptoms in this mouse model. We confirmed that at 5 months of age, enrichment ameliorates motor symptoms ( assessed using the rotarod test) and prevents loss of body weight induced by the HD transgene. We further examined molecular consequences of enrichment by determining changes in protein levels in the neostriatum, hippocampus, and anterior cortex using quantitative Western blot analysis. Non-enriched HD mice have severe reductions in BDNF in the hippocampus and striatum at 5 months, which are entirely rescued by enrichment. BDNF levels are unaltered by HD in the anterior cortex, suggesting that enrichment might prevent HD-induced impairment of anterograde transport of this neurotrophin to the striatum. NGF is unaffected by HD. Non-enriched HD mice also exhibit deficits in dopamine and cAMP-regulated phosphoprotein ( 32 kDa) in striatum and anterior cortex. Environmental enrichment rescues the cortical but not the striatal deficit at 5 months. These results suggest that environmental enrichment benefits animals at early stages of the disease by rescuing protein deficits, possibly through rescuing transcription or protein transport problems.
引用
收藏
页码:2270 / 2276
页数:7
相关论文
共 54 条
[1]   Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington's disease [J].
Alberch, J ;
Pérez-Navarro, E ;
Canals, JM .
BRAIN RESEARCH BULLETIN, 2002, 57 (06) :817-822
[2]   Anterograde transport of brain-derived neurotrophic factor and its role in the brain [J].
Altar, CA ;
Cai, N ;
Bliven, T ;
Juhasz, M ;
Conner, JM ;
Acheson, AL ;
Lindsay, RM ;
Wiegand, SJ .
NATURE, 1997, 389 (6653) :856-860
[3]   CHEMICAL + ANATOMICAL PLASTICITY OF BRAIN - CHANGES IN BRAIN THROUGH EXPERIENCE DEMANDED BY LEARNING THEORIES ARE FOUND IN EXPERIMENTS WITH RATS [J].
BENNETT, EL ;
KRECH, D ;
DIAMOND, MC ;
ROSENZWEIG, MR .
SCIENCE, 1964, 146 (364) :610-+
[4]   Adenoviral brain-derived neurotrophic factor induces both neostriatal and olfactory neuronal recruitment from endogenous progenitor cells in the adult forebrain [J].
Benraiss, A ;
Chmielnicki, E ;
Lerner, K ;
Roh, D ;
Goldman, SA .
JOURNAL OF NEUROSCIENCE, 2001, 21 (17) :6718-6731
[5]   Hippocampal brain-derived neurotrophic factor gene regulation by exercise and the medial septum [J].
Berchtold, NC ;
Kesslak, JP ;
Cotman, CW .
JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 68 (05) :511-521
[6]   Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice [J].
Bibb, JA ;
Yan, Z ;
Svenningsson, P ;
Snyder, GL ;
Pieribone, VA ;
Horiuchi, A ;
Nairn, AC ;
Messer, A ;
Greengard, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (12) :6809-6814
[7]  
Bizon JL, 1999, J COMP NEUROL, V408, P283
[8]   Differential regulation of the expression of nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 after excitotoxicity in a rat model of Huntington's disease [J].
Canals, JM ;
Marco, S ;
Checa, N ;
Michels, A ;
Pérez-Navarro, E ;
Arenas, E ;
Alberch, J .
NEUROBIOLOGY OF DISEASE, 1998, 5 (05) :357-364
[9]   Expression of brain-derived neurotrophic factor in cortical neurons is regulated by striatal target area [J].
Canals, JM ;
Checa, N ;
Marco, S ;
Åkerud, P ;
Michels, A ;
Pérez-Navarro, E ;
Tolosa, E ;
Arenas, E ;
Alberch, J .
JOURNAL OF NEUROSCIENCE, 2001, 21 (01) :117-124
[10]   Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene [J].
Cha, JHJ ;
Kosinski, CM ;
Kerner, JA ;
Alsdorf, SA ;
Mangiarini, L ;
Davies, SW ;
Penney, JB ;
Bates, GP ;
Young, AB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) :6480-6485